Terms: = Skin cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
53 results:
1. RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma.
Jiang Y; Hu X; Wang Z; Zhang Q; Chen D; Zhao P
Invest New Drugs; 2024 Feb; 42(1):60-69. PubMed ID: 38071684
[TBL] [Abstract] [Full Text] [Related]
2. The promoting effects of Grin2d expression in tumorigenesis and the aggressiveness of esophageal cancer.
Wang LL; Li J; Xue H; Zhang L; Yu DY; Yang N; Yun WJ; Zhao MZ; Xue H
Histol Histopathol; 2024 May; 39(5):659-670. PubMed ID: 37982578
[TBL] [Abstract] [Full Text] [Related]
3. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
4. Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study.
Fázio MR; Cristelli MP; Tomimori J; Koga CE; Ogawa MM; Beneventi GT; Tedesco-Silva H; Medina-Pestana J
J Bras Nefrol; 2023; 45(4):480-487. PubMed ID: 37565728
[TBL] [Abstract] [Full Text] [Related]
5. Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.
Aoude LG; Brosda S; Ng J; Lonie JM; Belle CJ; Patel K; Koufariotis LT; Wood S; Atkinson V; Smithers BM; Pearson JV; Waddell N; Barbour AP; Bonazzi VF
J Mol Diagn; 2023 Oct; 25(10):771-781. PubMed ID: 37544359
[TBL] [Abstract] [Full Text] [Related]
6. ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK/mtor pathway in melanoma.
Wang M; Zeng G; Xiong B; Zhu X; Guo J; Chen D; Zhang S; Luo M; Guo L; Cai L
Biochem Pharmacol; 2023 Jun; 212():115554. PubMed ID: 37080437
[TBL] [Abstract] [Full Text] [Related]
7. miRNAs as potential game-changers in melanoma: A comprehensive review.
Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
[TBL] [Abstract] [Full Text] [Related]
8. MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
[TBL] [Abstract] [Full Text] [Related]
9. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features, MCPyV status and outcomes of Merkel cell carcinoma in solid-organ transplant recipients: a retrospective, multicentre cohort study.
Ferrándiz-Pulido C; Gómez-Tomás A; Llombart B; Mendoza D; Marcoval J; Piaserico S; Baykal C; Bouwes-Bavinck JN; Rácz E; Kanitakis J; Harwood CA; Cetkovská P; Geusau A; Del Marmol V; Masferrer E; Orte Cano C; Ricar J; de Oliveira WR; Salido-Vallejo R; Ducroux E; Gkini MA; López-Guerrero JA; Kutzner H; Kempf W; Seçkin D
J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):1991-2001. PubMed ID: 35607918
[TBL] [Abstract] [Full Text] [Related]
11. The Overexpression of SLC25A13 Predicts Poor prognosis and Is Correlated with Immune Cell Infiltration in Patients with skin Cutaneous Melanoma.
Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
[TBL] [Abstract] [Full Text] [Related]
12. Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition.
Chowers G; Abebe-Campino G; Golan H; Vivante A; Greenberger S; Soudack M; Barkai G; Fox-Fisher I; Li D; March M; Battig MR; Hakonarson H; Adams D; Dori Y; Dagan A
Pediatr Res; 2023 Dec; 94(6):1911-1915. PubMed ID: 35246606
[TBL] [Abstract] [Full Text] [Related]
13. Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review.
Beaudoux O; Oudart JB; Riffaud L; Visseaux L; Marchal A; Lebre AS; Grange F
Mol Diagn Ther; 2022 Mar; 26(2):189-202. PubMed ID: 35195858
[TBL] [Abstract] [Full Text] [Related]
14. The novel AKT inhibitor afuresertib suppresses human Merkel cell carcinoma MKL-1 cell growth.
Wu JH; Limmer AL; Narayanan D; Doan HQ; Simonette RA; Rady PL; Tyring SK
Clin Exp Dermatol; 2021 Dec; 46(8):1551-1554. PubMed ID: 34115902
[TBL] [Abstract] [Full Text] [Related]
15. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
[TBL] [Abstract] [Full Text] [Related]
16. BAP1 antagonizes WWP1-mediated transcription factor KLF5 ubiquitination and inhibits autophagy to promote melanoma progression.
Jia X; Chen H; Ren Y; Dejizhuoga ; Gesangyuzhen ; Gao N; Feng H; Huang W; Liao Y; Yu H
Exp Cell Res; 2021 May; 402(1):112506. PubMed ID: 33516665
[TBL] [Abstract] [Full Text] [Related]
17. Pharmacological Inhibition of mtorC2 Reduces Migration and Metastasis in Melanoma.
Guenzle J; Akasaka H; Joechle K; Reichardt W; Venkatasamy A; Hoeppner J; Hellerbrand C; Fichtner-Feigl S; Lang SA
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375117
[TBL] [Abstract] [Full Text] [Related]
18. PD-1 expression on uveal melanoma induces tumor proliferation and predicts poor patient survival.
Jiang Z; Yan Y; Dong J; Duan L
Int J Biol Markers; 2020 Sep; 35(3):50-58. PubMed ID: 32686562
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts.
Fang B; Kannan A; Zhao S; Nguyen QH; Ejadi S; Yamamoto M; Camilo Barreto J; Zhao H; Gao L
Sci Rep; 2020 Jun; 10(1):8867. PubMed ID: 32483262
[TBL] [Abstract] [Full Text] [Related]
20. Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma.
Decaudin D; Frisch Dit Leitz E; Nemati F; Tarin M; Naguez A; Zerara M; Marande B; Vivet-Noguer R; Halilovic E; Fabre C; Jochemsen A; Roman-Roman S; Alsafadi S
Eur J Cancer; 2020 Feb; 126():93-103. PubMed ID: 31927215
[TBL] [Abstract] [Full Text] [Related]
[Next]
